In March 2020, the Company completed an Asset Purchase Agreement (the “Purchase Agreement”) with Wittenstein SE (“Wittenstein”), a privately-held German-based company, to acquire assets associated with the FITBONE intramedullary lengthening system for limb lengthening of the femur and tibia bones for $18.0 million in cash consideration. The Company also entered into a Contract Manufacturing and Supply Agreement (“CMSA”) with Wittenstein, which was accounted for as a finance lease.

In July 2020, the Company acquired certain assets of a medical device distributor for consideration of up to $7.6 million.

Purchase Price Allocations for Completed Acquisitions Discussed Above


(U.S. Dollars, in thousands)	FITBONE		Assigned Useful Life	Distributor Acquisition		Assigned Useful Life
Assets acquired
Inventories	$	528		$	—
Other long-term assets		—			—
Intangible assets
Customer relationships		800	15 years		7,340	5 years
Developed technology		4,500	8 years		—	N/A
In-process research and development ("IPR&D")		300	Indefinite		—	N/A
Trade name		600	15 years		—	N/A
Assembled workforce		—	N/A		235	5 years
Total identifiable assets acquired	$	6,728		$	7,575
Liabilities assumed		—			—
Goodwill		11,272			—
Total fair value of consideration transferred	$	18,000		$	7,575